VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/33734063/

⇱ Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa) - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

The strategy in New Zealand (Aotearoa) to eliminate coronavirus disease requires that international arrivals undergo managed isolation and quarantine and mandatory testing for severe acute respiratory syndrome coronavirus 2. Combining genomic and epidemiologic data, we investigated the origin of an acute case of coronavirus disease identified in the community after the patient had spent 14 days in managed isolation and quarantine and had 2 negative test results. By combining genomic sequence analysis and epidemiologic investigations, we identified a multibranched chain of transmission of this virus, including on international and domestic flights, as well as a probable case of aerosol transmission without direct person-to-person contact. These findings show the power of integrating genomic and epidemiologic data to inform outbreak investigations.

Keywords: COVID-19; New Zealand; SARS-CoV-2; air travel; border quarantine; case-patients; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Figures

👁 Figure 1
Figure 1
Sequence of probable transmission events and associated relevant locations in-flight and MIQ for severe acute respiratory syndrome coronavirus 2 during border quarantine and air travel, New Zealand, September 2020. Location of case A is approximate (Table). COVID-19, coronavirus disease; MIQ, managed isolation and quarantine.
👁 Figure 2
Figure 2
Phylogenetic trees showing genomic relationship of severe acute respiratory syndrome coronavirus 2 genomes generated for 9 case-patients, New Zealand, September 2020. Shown are number of mutations, as well as the F.1 cluster (red) within the context of the closest ancestral B.1.36.17 lineage (black). Scale bar indicates nucleotide substitutions per site. MIQ, managed isolation and quarantine.

References

    1. Jefferies S, French N, Gilkison C, Graham G, Hope V, Marshall J, et al. COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study. Lancet Public Health. 2020;5:e612–23. 10.1016/S2468-2667(20)30225-5 - DOI - PMC - PubMed
    1. Baker MG, Wilson N, Anglemyer A. Successful elimination of COVID-19 transmission in New Zealand. N Engl J Med. 2020;383:e56. 10.1056/NEJMc2025203 - DOI - PMC - PubMed
    1. Geoghegan JL, Moreland NJ, Le Gros G, Ussher JE. New Zealand’s science-led response to the SARS-CoV-2 pandemic. Nat Immunol. 2021;22:262–3. 10.1038/s41590-021-00872-x - DOI - PubMed
    1. The Lancet Respiratory Medicine. COVID-19 transmission-up in the air. [editorial]. Lancet Respir Med. 2020;8:1159. 10.1016/S2213-2600(20)30514-2 - DOI - PMC - PubMed
    1. Geoghegan JL, Douglas J, Ren X, Storey M, Hadfield J, Silander OK, et al. Use of genomics to track coronavirus disease outbreaks, New Zealand. Emerg Infect Dis. 2021. In press. - PMC - PubMed

LinkOut - more resources

Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.